Beyond Beer and Viagra: Mergers, Treasuries and IPOs of the Week
The latest hot M&A talk meets a mysterious mound of U.S. Treasuries piling up offshore. And we see rough times ahead for IPOs…
View ArticleMake 5 Times Your Money Piggybacking Secret Government Executive Dividends
Uncover the safest way to make multiples of your money. The three best opportunities have an expiration date, so act fast.
View ArticleSell Half — Book a 183% Gain
We've held these shares in the MTA portfolio for over thirteen months. We bought in at 61-cents per share in March 2013. Back then, I saw immense potential in the company. At one point, the share price...
View ArticleA “Baby Bakken” Profit Play
When it comes to America's shale boom, the mainstream media continue to lag. Today, this "information lag" is our chance to cash in. With drill bits spinning out west, and oil set to flow, now's the...
View ArticleHow to Play the Coming IPO Crash
Lately, the market seems to be obsessed with new tech darlings with flashy names and exciting stories. But there are more sinister forces at work... Today Greg Guenthner explains why you should pay no...
View ArticleOur Portfolio Is Weathering the Test
Despite the slams that biotech and tech stocks have taken in the last month, I have been encouraged by how resilient most of our portfolio has proven to be and especially how much bounce-back there has...
View ArticleShareholders Kick Down the Gates
The “Wall Street Rule” repealed… and your chance to seize the moment. Plus: A sector where foolish investors can’t resist buying high and selling low
View ArticleThe March of the Activists
The “Wall Street Rule” repealed… and your chance to seize the moment. Plus: A sector where foolish investors can’t resist buying high and selling low
View ArticleStrategic Vision’s 3 Charts on the China Bubble
We predict the biggest surprise of financial markets in 2014.
View ArticleA Simple Strategy for Investing in the US Energy Boom
Too often investments are made in a vacuum. But as Byron King demonstrates, the global economic crash... easy money... and technological advancements are all interdependent. In particular, that...
View ArticleThe FDA Trader Bible
Welcome to the FDA Trader Bible, your short guide and first stop on the road to biotech riches. In this no-nonsense guidebook, I’ve laid out everything you need to know about FDA trading in plain,...
View ArticleThe Magic Calendar
As you know by now, there are 36 “magic dates” over the next 12 months that act as little-known price triggers for some of the hottest stocks on Wall Street. These dates refer to when certain drugs are...
View ArticleRising Mil-Tech: The “End of History” Has Been Postponed
In the past few years, we saw preliminary hits to the Defense budget, with "sequestration" and such. Now, however, the problem for budget writers is that there's an entirely new strategic situation in...
View ArticleImproved Odds for Early Approval Send Our Pick Zooming
It's been rough for biotechnology stocks. The Nasdaq Biotechnology Index was down 20% early last week from its late February peak. The S&P Biotechnology index was off even worse, down 26%. These...
View ArticleThe Ultimate Win-Win
Doing well by doing good: The $80 billion battle against cancer. Plus: Amazon swoons, because suddenly profits matter. And: The chart that could drag the United States into a major war
View ArticleThe “Chicago Catalyst” for New Biotech Profits
Doing well by doing good: The $80 billion battle against cancer. Plus: Amazon swoons, because suddenly profits matter. And: The chart that could drag the United States into a major war
View ArticleDon’t Miss The Biggest Biotech Market EVER!
You're likely to hear a lot of sad sack investors talk about the dangers of investing in biotech. Don't listen to them. According to Paul Mampilly, those crying "biotech bubble" are just sore losers....
View ArticleEnergy & Metals: Target-Rich Investment Environment
All manner of things are happening on every front of the resource sector. So instead of focusing this week's update on just one or two items, as I often do, I have a comments on a variety of topics....
View ArticleYour Editor, the Early Adopter on the Planet’s Largest Hotel Chain
It's been hectic. As I told you in my last update, I'll be traveling over the next few weeks. I'm off to Omaha next week. New York City the week after that...
View ArticleHas the Gold Sector Bottomed?
Bulls are thriving on M&A and stock buybacks -- not earnings success. So what does that mean in the gold sector? Here’s our answer.
View Article